Table 2 Information about the risks and benefits of breast cancer screening by Italian public health organisations in 2021 and 2014
From: Online information about mammography screening in Italy from 2014 to 2021
2021 134 documents | 2014 136 documents | |||||
|---|---|---|---|---|---|---|
n | q | % | n | q | % | |
Risks | ||||||
False-positive result | 57 | 5 | 42.5 | 42 | 4 | 30.8 |
Biopsy-proven false-positive result | 14 | 0 | 10.4 | 2 | 0 | 1.4 |
False-negative result | 42 | 1 | 31.3 | 27 | 5 | 19.9 |
Interval cancer | 48 | 2 | 35.8 | 30 | 3 | 22.1 |
Overdiagnosis | 27 | 11 | 20.1 | 11 | 3 | 8.0 |
Radiation exposure | 38 | 0 | 28.3 | 40 | 0 | 29.4 |
Total risk | 226 | 152 | ||||
Total quantitative data on risks | 19 | 8.4 | 15 | 9.8 | ||
Benefits | ||||||
Reduced breast cancer mortality | 78 | 58.2 | 47 | 34.5 | ||
Quantitative data on Reduced breast cancer mortality | 13 | 16.7 | 17 | 36.2 | ||